Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
China Shineway Pharmaceutical Group Limited ( (HK:2877) ) has shared an announcement.
China Shineway Pharmaceutical Group Limited announced that all resolutions proposed at its Annual General Meeting on May 29, 2025, were successfully passed. The resolutions included the re-election of directors, authorization for the board to fix directors’ remuneration, re-appointment of auditors, and granting of mandates to repurchase and issue shares. This outcome reflects strong shareholder support and positions the company for continued strategic operations and governance.
More about China Shineway Pharmaceutical Group Limited
China Shineway Pharmaceutical Group Limited is a company incorporated in the Cayman Islands, operating in the pharmaceutical industry. It focuses on the production and distribution of pharmaceutical products, primarily serving markets with a demand for traditional Chinese medicine and other healthcare solutions.
Average Trading Volume: 1,335,804
Technical Sentiment Signal: Hold
Current Market Cap: HK$5.63B
See more insights into 2877 stock on TipRanks’ Stock Analysis page.